It's very difficult to get a DMV appointment to stay compliant and get an enhanced or REAL ID, and some people in the ...

A 77-year-old Vermont man was killed on Sunday afternoon while attempting to rescue a turtle on Interstate 95 in Indian River ...

Amithraz Balgobin, 36, allegedly attacked Amaratial Mistry at a property in Streatham, south London, on Friday July 4.

DEAR MISS MANNERS: I am a gentleman who strives to live a mannerly life. In that regard, when riding public transportation, I ...

An elderly couple who hired a contractor to renovate their roof claims they were scammed out of tens of thousands of dollars, ...

The NYPD is searching for a suspect who assaulted a man in Brooklyn and has issued an appeal for public assistance. The ...

Maria Pasqual was a flower farmer in Maili, loved by those who encountered her. The family who lives next door to her farm ...

A missing elderly woman with dementia has been found deceased in Daviess County. Lola Davis, 89, of Mt. Vernon, Indiana, went ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY® (sebetralstat), a novel ...

When Kiara Miller noticed Mr. Johnson sitting alone in his usual booth at a Blairsville diner, she knew something was up.

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.

The Food and Drug Administration (FDA) has approved Ekterly ® (sebetralstat) for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.